Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Liabilities and Shareholders Equity: 2021-2022

Historic Liabilities and Shareholders Equity for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $85.8 million.

  • Milestone Pharmaceuticals' Liabilities and Shareholders Equity fell 35.89% to $85.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $402.7 million, marking a year-over-year change of. This contributed to the annual value of $119.8 million for FY2021, which is N/A change from last year.
  • According to the latest figures from Q3 2022, Milestone Pharmaceuticals' Liabilities and Shareholders Equity is $85.8 million, which was down 6.06% from $91.3 million recorded in Q2 2022.
  • In the past 5 years, Milestone Pharmaceuticals' Liabilities and Shareholders Equity ranged from a high of $145.5 million in Q2 2021 and a low of $85.8 million during Q3 2022.
  • For the 2-year period, Milestone Pharmaceuticals' Liabilities and Shareholders Equity averaged around $117.2 million, with its median value being $119.8 million (2021).
  • Data for Milestone Pharmaceuticals' Liabilities and Shareholders Equity shows a maximum YoY slumped of 37.25% (in 2022) over the last 5 years.
  • Milestone Pharmaceuticals' Liabilities and Shareholders Equity (Quarterly) stood at $119.8 million in 2021, then plummeted by 35.89% to $85.8 million in 2022.
  • Its Liabilities and Shareholders Equity was $85.8 million in Q3 2022, compared to $91.3 million in Q2 2022 and $105.8 million in Q1 2022.